These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33627051)

  • 1. Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials.
    Pepperrell T; Rodgers F; Tandon P; Sarsfield K; Pugh-Jones M; Rashid T; Keestra S
    Glob Health Action; 2021 Jan; 14(1):1892309. PubMed ID: 33627051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review.
    Kou R; Sadafi SL; Principato R; Anderson LN; Brignardello-Petersen R; Mbuagbaw L
    J Clin Epidemiol; 2024 May; 169():111315. PubMed ID: 38447854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic Disparities in COVID-19 Vaccine Mistrust and Receipt in British Columbia, Canada: Population Survey.
    Mahmood B; Adu P; McKee G; Bharmal A; Wilton J; Janjua NZ
    JMIR Public Health Surveill; 2024 Feb; 10():e48466. PubMed ID: 38363596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate Minority Representation within SARS-CoV-2 Vaccine Trials.
    Craft JF; Travassos MA; Foppiano Palacios C; Openshaw JJ
    Am J Trop Med Hyg; 2021 Jan; 104(1):32-34. PubMed ID: 33200726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora.
    Xu Q; McMann TJ; Li J; Wenzel C; Mackey TK
    Trials; 2023 Dec; 24(1):790. PubMed ID: 38053216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank.
    Raisi-Estabragh Z; McCracken C; Bethell MS; Cooper J; Cooper C; Caulfield MJ; Munroe PB; Harvey NC; Petersen SE
    J Public Health (Oxf); 2020 Aug; 42(3):451-460. PubMed ID: 32556213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine.
    Hill J; Montross D; Ivarsson M
    Front Public Health; 2023; 11():1113003. PubMed ID: 37181705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of COVID-19 vaccines by race and ethnicity.
    Salari N; Vepa A; Daneshkhah A; Darvishi N; Ghasemi H; Khunti K; Mohammadi M
    Public Health; 2022 Jul; 208():14-17. PubMed ID: 35660280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
    Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
    Trials; 2021 Apr; 22(1):296. PubMed ID: 33879208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccinations among Black Asian and Minority Ethnic (BAME) groups: Learning the lessons from influenza.
    Acharya A; Lam K; Danielli S; Ashrafian H; Darzi A
    Int J Clin Pract; 2021 Oct; 75(10):e14641. PubMed ID: 34379339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
    Dal-Ré R; Bekker LG; Gluud C; Holm S; Jha V; Poland GA; Rosendaal FR; Schwarzer-Daum B; Sevene E; Tinto H; Voo TC; Sreeharan N
    Lancet Infect Dis; 2021 Nov; 21(11):e342-e347. PubMed ID: 34019801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    Watkinson RE; Williams R; Gillibrand S; Sanders C; Sutton M
    PLoS Med; 2022 Mar; 19(3):e1003932. PubMed ID: 35239661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
    PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.